Nutrition and Cachexia in Cancer Patients
Over the last years cancer care has seen a lot of developments regarding multidisciplinary approaches and the term patient-centered care has been proposed to encompass both supportive and palliative care. There is also a shift from traditional palliative (“end of life”) to early supportive care in cancer patients. Furthermore, dedicated outpatient supportive care teams have been being developed to focus on prevention and management of anticancer treatment toxicities.
Cachexia and malnutrition are important predictors of anticancer treatment success; thus, cachexia and malnutrition should be detected at cancer diagnosis, treated as early as possible and monitored through the whole patient journeys to improve the patients’ quality of life. In clinical practice, however, cachexia and malnutrition frequently go unrecognized and untreated with negative impact on cancer patients’ quality of life and outcome.
Raise awareness and build knowledge on the transversal role of cachexia and malnutrition diagnosis and nutrition therapy (incl. parenteral nutrition) as integral part of a multimodal supportive care approach in cancer patients.
Project target group
Health care professionals and other decision makers (including budget holders, policy makers) able to drive integration of better malnutrition/cachexia/sarcopenia diagnosis and therapy (including parenteral nutrition) in cancer care pathways.
Position paper (including call for action) being published in high-ranked, peer-reviewed journal targeting health care professionals and decision makers (including budget holders, policy makers) in cancer care.
Task force with 6-8 experts to develop and publish a position paper (including call for action), 2-3 task force meetings.
Task force could be partly seen as a re-vitalization of earlier task force focusing on cachexia.
The First Task Force meeting will be held on 22 June 2020 as a virtual Task Force videoconference.
Click here for further information.
Matti Aapro, Clinique de Genolier - SPCC, Bellinzona
Jann Arends, Universitätsklinikum Freiburg
Maurizio Muscaritoli, Sapiensa University Rome